Lucinda Stebbins - Tekla Life Independent Trustee
| HQL Stock | USD 14.26 0.13 0.92% |
Executive
Ms. Lucinda H. Stebbins, CPA is Independent Trustee of HQ Life Sciences Investors. Ms. Stebbins brings to each Fund over twenty years experience working in the fund industry, providing valuable perspectives on a variety of technical and industry matters. She serves as Chairman of the Audit Committee and serves on the Governance and Nominating Committee of each Fund. She started her career with the investment management firm of Scudder, Stevens and Clark, which was later merged into the U.S. operations of Zurich Financial Services, and then finally acquired by Deutsche Bank. She served as a Senior Vice President at Scudder Investments and subsequently as a Director at Deutsche Asset Management and was an officer of approximately 200 funds in these complexes since 2006.
| Age | 73 |
| Tenure | 18 years |
| Professional Marks | CPA |
| Address | 1900 Market Street, Philadelphia, PA, United States, 19103 |
| Phone | 215 405 5700 |
| Web | https://www.teklacap.com/hql.html |
Lucinda Stebbins Latest Insider Activity
Tracking and analyzing the buying and selling activities of Lucinda Stebbins against Tekla Life stock is an integral part of due diligence when investing in Tekla Life. Lucinda Stebbins insider activity provides valuable insight into whether Tekla Life is net buyers or sellers over its current business cycle. Note, Tekla Life insiders must abide by specific rules, including filing SEC forms every time they buy or sell Tekla Life'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Lucinda Stebbins over six months ago Insider Trading |
Tekla Life Management Efficiency
The value of Return On Tangible Assets is estimated to slide to 0.04. The value of Return On Capital Employed is expected to slide to -0.02. At this time, Tekla Life's Total Current Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.06 this year, although the value of Total Assets will most likely fall to about 335.6 M. Tekla Life's management efficiency ratios could be used to measure how well Tekla Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Cynthia Egan | Blackrock Muniyield | 66 | |
| Carole Stone | Nuveen Preferred and | 74 | |
| Jay Fife | Blackrock Muniyield | 51 | |
| James Kirchner | Eaton Vance Risk | 54 | |
| Roger Ko | Flaherty Crumrine Preferred | 45 | |
| Frank Fabozzi | Blackrock Muniyield | 73 | |
| Helen Peters | Eaton Vance Tax | 73 | |
| Warren Thomson | John Hancock Financial | 64 | |
| Charles Park | Blackrock Muniyield | 54 | |
| Laura Woodward | Tekla Healthcare Opportunities | 51 | |
| Francis Knox | John Hancock Financial | 73 | |
| Cynthia Frost | Eaton Vance Tax | 60 | |
| Laurie Lodolo | Flaherty and Crumrine | 56 | |
| Susan Sutherland | Eaton Vance Tax | 64 | |
| Cedric Antosiewicz | Nuveen Preferred and | 57 | |
| William Reardon | Tekla World Healthcare | 74 | |
| Robert Keith | First Trust Intermediate | 64 | |
| Dr MS | Tekla Healthcare Investors | 71 | |
| Laura Woodward | Tekla Healthcare Investors | 51 | |
| Cynthia Frost | Eaton Vance Risk | 60 | |
| Peter Burgess | John Hancock Financial | 78 | |
Management Performance
| Return On Equity | 0.0128 | |||
| Return On Asset | -0.0032 |
Tekla Life Sciences Leadership Team
Elected by the shareholders, the Tekla Life's board of directors comprises two types of representatives: Tekla Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tekla. The board's role is to monitor Tekla Life's management team and ensure that shareholders' interests are well served. Tekla Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tekla Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Kent, Independent Trustee | ||
| William Reardon, Independent Trustee | ||
| Elizabeth Nabel, Independent Trustee | ||
| Oleg Pohotsky, Independent Chairman of the Board of Trustees | ||
| Laura Woodward, Chief Compliance Officer, Treasurer, Secretary | ||
| Dr MS, President Officer | ||
| Peter Branner, Chief Officer | ||
| Lucinda Stebbins, Independent Trustee | ||
| Jeffrey Bailey, Independent Trustee | ||
| Daniel Omstead, Principal Executive Officer and President Trustee and Member of Valuation Committee | ||
| Rakesh Jain, Independent Trustee |
Tekla Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tekla Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0128 | |||
| Return On Asset | -0.0032 | |||
| Profit Margin | 1.56 % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 370.8 M | |||
| Shares Outstanding | 27.35 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 35.35 % | |||
| Number Of Shares Shorted | 74.12 K | |||
| Price To Earning | 2.84 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.3 | Earnings Share 1.34 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.